CClinicalTrials.gg
Not yet recruitingNCT07326228Updated Jan 8, 2026

Effect of Exercises on Ventilatory Function in Adult With TOF

An interventional study of aerobic exercise and respiratory muscle training in Tetralogy of Fallot (TOF) and Adults With Repaired Tetralogy of Fallot, sponsored by Cairo University. Not yet recruiting. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Cairo University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if combined inspiratory muscle training and aerobic exercise can improve ventilatory function in adults with repaired Tetralogy of Fallot (TOF). It will also learn if exercises work to raise functional capacity and Quality of life (QoL) . The main questions it aims to answer is:

  • Dose combined inspiratory muscle training and aerobic exercise (study group) improve ventilatory function in adults with repaired (TOF) more than aerobic exercise only (control group)?
  • Can combine inspiratory muscle training and aerobic exercise (study group) raise functional capacity and (QoL) in adults with repaired (TOF) more than aerobic exercise only (control group)?

Researchers will compare between combination of inspiratory muscle training and aerobic exercise on one group and the aerobic exercise only on other group, on ventilatory function, functional capacity and (QoL) on adults with repaired TOF.

Participants will:

On study group , participants will perform respiratory muscle training in addition to moderate intensity aerobic exercise for 6 weeks. 3 times/week

On controlled group , participants will perform moderate intensity aerobic exercise for 6 weeks. 3 times/week.

all participants will test ventilatory function , functional capacity and will answer a survey questions about their quality of life before and after training

02

Conditions studied

  • Tetralogy of Fallot (TOF)
  • Adults With Repaired Tetralogy of Fallot

Keywords

  • congenital heart disease
  • tetralogy of Fallot
  • inspiratory muscle training
  • aerobic exercise
  • ventilatory functions
  • functional capacity
  • Quality of life
03

In context

Tetralogy of Fallot

93 studies on the registry are indexed under Tetralogy of Fallot; 26 are open to participants now.

This study's planned enrollment of 60 is above the median of 51 across 52 interventional studies indexed under Tetralogy of Fallot.

Browse Tetralogy of Fallot studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with TOF.
  • Have surgical correction of the abnormality.
  • Class II-III according to New York Heart Association (NYHA)
  • Ejection fracture > 40
  • Vitally stable during the study period

Exclusion criteria

Exclusion Criteria:

  • Resent cardiopulmonary surgery or intervention "less than 6 months"
  • Presence of pulmonary disease which is not a complication of TOF (eg:

bronchial asthma, lung fibrosis…..)

  • Neuromuscular or musculoskeletal disease and severe scoliosis affecting pulmonary function or physical exercise.
  • Mental or physical limitations
  • active infection or systemic illness.
  • Hemodynamic instability
  • Mouth burn, injury, or deformities
  • Implanted pacemaker
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    combined respiratory muscle training and aerobic training

    participants will receive respiratory muscle training via threshold IMT device in addition to moderate intensity aerobic exercise

    Other: aerobic exercise · Other: respiratory muscle training

  • Active comparator
    aerobic exercise

    participants will receive moderate intensity aerobic exercise

    Other: aerobic exercise

Interventions

  • Otheraerobic exercise

    moderate intensity aerobic exercises on a treadmill: * Symptom-limited treadmill exercise training will be carried out at baseline for each participant following the modified Bruce protocol to estimate each participant's peak heart rate. * the target heart rate during training will be 50-60 % of each participant's heart rate reserve (moderate intensity exercise) * each session will have 5-10 min warm up, at least 20 min of moderate intensity aerobic exercise , and 5-10 min of cool down

  • Otherrespiratory muscle training

    respiratory muscle training via threshold inspiratory muscle trainer (IMT) device: * maximum inspiratory effort will be detected for each participant as the maximum resistance at which the participant can efficiently achieve 10 breathing cycles, via (Threshold IMT device) * the training will be initiated with a low-intensity load (20-30%) of the participant's maximum inspiratory effort via (Threshold IMT device). Then, the intensity will increase gradually by 5% according to the participant's tolerance weekly until achieving 50% of maximum inspiratory effort. * the session will be formed of six sets, each set consisting of five deep breaths against the (Threshold IMT device), with a short interval of 1-2-minute rest between sets.

    Also known as: Threshold inspiratory muscle training, inspiratory muscle training

06

What researchers measure

Primary outcomes

  1. "Change from Baseline in Ventilatory function : Forced vital capacity (FVC) , Forced expiratory volume in 1 second (FEV1), expiratory vital capacity (EVC) and inspiratory vital capacity (IVC).

    Time frame: At Baseline and after 6 weeks of training

Secondary outcomes

  1. Change from Baseline in Six-minute walk test (6MWT)

    Time frame: At Baseline and after 6 weeks of training

  2. changes from baseline in 36-Item Short Form Health Survey (SF-36)

    as an assessment of quality of live

    Time frame: at Baseline and after 6 weeks of training

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07326228
Lead sponsor
Cairo University
Responsible party
Omnia Ahmed Khalaf Ismail (Physical Therapist, Cairo University) — Principal investigator
First posted
Jan 8, 2026
Start date
Jan 1, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Jan 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion